Answers are grounded in this paper and cite their sources.
This systematic review evaluates virtual reality exposure therapy effects on anxiety and phobias, suggesting clinical applications and highlighting future research needs.
Background: This systematic review and meta-analysis examined virtual reality‐based exposure therapy (VRET) for treating anxiety and phobic disorders. Methods: We found 30 controlled studies (N=3,000) across common databases and followed PRISMA guidelines. Results: Primary outcomes were validated anxiety scales. Overall, VRET significantly reduced anxiety symptoms compared to no‐treatment or standard care. Meta-analytic effect sizes were large. In a broader anxiety sample, VRET outperformed conventional interventions (SMD = –0.95). Importantly, pooled analyses found no significant difference between VRET and in vivo exposure for most phobia types. Quality of evidence was mixed: most trials were small, and some risk-of-bias concerns were noted. Theoretical models align with these findings, suggesting that immersive VR exposure can produce habituation and new learning to inhibit fear. Clinically, VRET appears to be a viable alternative or adjunct to traditional CBT for anxiety, especially specific phobias and social anxiety. Yet heterogeneity and gaps remain, and longer-term, high-quality trials are needed. Conclusion: This report provides detailed methods and a critical appraisal of current evidence, with recommendations for practice and future research.
No takes yet. Share an insight, caveat, or question.
Okuagu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: